Skip to content

Olema Pharmaceuticals

US · OLMA #3521 by market cap Listed 2020
7.94 +0.02 +0.25%
Live - 5344 symbols - heartbeat 282s ago · 2026-10-08 07:38
Pre-market 8.10 +2.02%
After-hours 7.84 -1.32%
Market cap
694.73M
P/B
1.61
EPS
-1.87
Reader sentiment Are you bullish or bearish on OLMA?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Guggenheim Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $35
    Market Newswire · 2026/6/1
  • Rating change
    H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $38
    Market Newswire · 2026/6/3
  • Rating change
    LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $24
    Market Newswire · 2026/6/3
  • H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $36
    Market Newswire · 2026/9/21
  • A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $16 to $59
    Market Newswire · 2026/9/14
  • Rating change
    LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $29
    Market Newswire · 2026/5/18
  • Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $59
    Market Newswire · 2026/9/11
  • Rating change
    J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
    Market Newswire · 2026/8/11
  • Rating change
    Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/20
  • LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $16
    Market Newswire · 2026/9/15
  • Rating change
    Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $62
    Market Newswire · 2026/6/1
  • Rating change
    J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46
    Market Newswire · 2026/8/13
  • Stifel Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $30
    Market Newswire · 2026/9/15
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Olema Pharmaceuticals (OLMA) and CG Oncology, Inc. (CGON)
    TipRanks · 2026/5/26
  • Rating change
    LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24
    Market Newswire · 2026/7/14
  • Rating change
    J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $52
    Market Newswire · 2026/5/19
  • Rating change
    Goldman Sachs Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $23
    Market Newswire · 2026/5/14
  • Rating change
    J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/8/17
  • Rating change
    A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $23 to $48
    Market Newswire · 2026/5/13
  • Rating change
    A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $20 to $59
    Market Newswire · 2026/8/11

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:38:44 · For reference only, not investment advice and not tailored to your situation.